211 related articles for article (PubMed ID: 30046585)
1. Cerebellar lncRNA Expression Profile Analysis of SCA3/MJD Mice.
Long Z; Li T; Chen Z; Peng Y; Wang C; Hou X; Yuan H; Wang P; Xie Y; He L; Zhou X; Peng H; Qiu R; Xia K; Tang B; Jiang H
Int J Genomics; 2018; 2018():5383517. PubMed ID: 30046585
[TBL] [Abstract][Full Text] [Related]
2. Machado Joseph-Disease Is Rare in the Peruvian Population.
Cornejo-Olivas M; Solis-Ponce L; Araujo-Aliaga I; Milla-Neyra K; Ortega O; Illanes-Manrique M; Mazzetti P; Manrique-Enciso C; Cubas-Montecino D; Saraiva-Pereira ML; Jardim LB; Sarapura-Castro E
Cerebellum; 2023 Dec; 22(6):1192-1199. PubMed ID: 36323979
[TBL] [Abstract][Full Text] [Related]
3. RNA Expression Profile and Potential Biomarkers in Patients With Spinocerebellar Ataxia Type 3 From Mainland China.
Li T; Hou X; Chen Z; Peng Y; Wang P; Xie Y; He L; Yuan H; Peng H; Qiu R; Xia K; Tang B; Jiang H
Front Genet; 2019; 10():566. PubMed ID: 31249598
[TBL] [Abstract][Full Text] [Related]
4. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
5. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
6. Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD).
Haberhausen G; Damian MS; Leweke F; Müller U
J Neurol Sci; 1995 Sep; 132(1):71-5. PubMed ID: 8523034
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological, clinical, and molecular characterization of Cuban families with spinocerebellar ataxia type 3/Machado-Joseph disease.
González-Zaldívar Y; Vázquez-Mojena Y; Laffita-Mesa JM; Almaguer-Mederos LE; Rodríguez-Labrada R; Sánchez-Cruz G; Aguilera-Rodríguez R; Cruz-Mariño T; Canales-Ochoa N; MacLeod P; Velázquez-Pérez L
Cerebellum Ataxias; 2015; 2():1. PubMed ID: 26331044
[TBL] [Abstract][Full Text] [Related]
8. Gene-Related Cerebellar Neurodegeneration in SCA3/MJD: A Case-Controlled Imaging-Genetic Study.
Peng H; Liang X; Long Z; Chen Z; Shi Y; Xia K; Meng L; Tang B; Qiu R; Jiang H
Front Neurol; 2019; 10():1025. PubMed ID: 31616370
[No Abstract] [Full Text] [Related]
9. Two novel SNPs in ATXN3 3' UTR may decrease age at onset of SCA3/MJD in Chinese patients.
Long Z; Chen Z; Wang C; Huang F; Peng H; Hou X; Ding D; Ye W; Wang J; Pan Q; Li J; Xia K; Tang B; Ashizawa T; Jiang H
PLoS One; 2015; 10(2):e0117488. PubMed ID: 25689313
[TBL] [Abstract][Full Text] [Related]
10. Six cases of SCA3/MJD patients that mimic hereditary spastic paraplegia in clinic.
Wang YG; Du J; Wang JL; Chen J; Chen C; Luo YY; Xiao ZQ; Jiang H; Yan XX; Xia K; Pan Q; Tang BS; Shen L
J Neurol Sci; 2009 Oct; 285(1-2):121-4. PubMed ID: 19608203
[TBL] [Abstract][Full Text] [Related]
11. Case report: Short-term efficacy and changes in
Cui Z; Lan Y; Chang Y; Liu X; Wang J; Lou X; Wang R
Front Neurol; 2023; 14():1246430. PubMed ID: 37830087
[TBL] [Abstract][Full Text] [Related]
12. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
13. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease.
Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142
[TBL] [Abstract][Full Text] [Related]
15. Planning Future Clinical Trials for Machado-Joseph Disease.
Saute JAM; Jardim LB
Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
[TBL] [Abstract][Full Text] [Related]
16. Profiling of mitochondrial genomes in SCA3/MJD patients from mainland China.
Yuan H; Yang H; Peng L; Peng Y; Chen Z; Wan L; Wang C; Shi Y; Zhang VW; Tang B; Qiu R; Jiang H
Gene; 2020 May; 738():144487. PubMed ID: 32087274
[TBL] [Abstract][Full Text] [Related]
17. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
Dürr A; Stevanin G; Cancel G; Duyckaerts C; Abbas N; Didierjean O; Chneiweiss H; Benomar A; Lyon-Caen O; Julien J; Serdaru M; Penet C; Agid Y; Brice A
Ann Neurol; 1996 Apr; 39(4):490-9. PubMed ID: 8619527
[TBL] [Abstract][Full Text] [Related]
18. Brain structural abnormalities in the preclinical stage of Machado-Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3): evaluation by MRI morphometry, diffusion tensor imaging and neurite orientation dispersion and density imaging.
Li M; Chen X; Xu HL; Huang Z; Chen N; Tu Y; Gan S; Hu J
J Neurol; 2022 Jun; 269(6):2989-2998. PubMed ID: 34783886
[TBL] [Abstract][Full Text] [Related]
19. Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n.
Jardim LB; Pereira ML; Silveira I; Ferro A; Sequeiros J; Giugliani R
Arch Neurol; 2001 Jun; 58(6):899-904. PubMed ID: 11405804
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
